Consistent Reduction in HAE Attack Rate with Lanadelumab Regardless Of Baseline Attack Frequency: Interim Findings From the Phase 3 HELP Study Open Label Extension (OLE)

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 145; no. 2; p. AB103
Main Authors Banerji, Aleena, Riedl, Marc, Tachdjian, Raffi, Nurse, Christina, Paes, Kim, Li, Huamin, Kiani-Alikhan, Sorena
Format Journal Article
LanguageEnglish
Published 01.02.2020
Online AccessGet full text

Cover

More Information
ISSN:0091-6749
DOI:10.1016/j.jaci.2019.12.622